Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
29
2022
PBM Regulatory Roundup (Spring 2022): The 8th Circuit Rules and More States Issue Regulations Mintz
Mar
29
2022
Consent Decree Entered Against Raw Animal Food Manufacturer Keller and Heckman LLP
Mar
28
2022
In the Weeds: Why Arbitration May Be the Key to Preserving Enforcement of Cannabis M&A and VC Contracts K&L Gates
Mar
28
2022
FDA Seeks OMB Approval of Consumer Research Plans for “Healthy” Symbol Keller and Heckman LLP
Mar
25
2022
McDermottPlus Check-Up: March 25, 2022 [PODCAST] McDermott Will & Emery
Mar
25
2022
Judge Questions Plausibility of “0g Total Sugar” Claim Keller and Heckman LLP
Mar
24
2022
FDA Webinar on Foodborne Outbreak Response Keller and Heckman LLP
Mar
24
2022
HHS OIG Signs Off on Substance Use Recovery Incentive Program Sheppard, Mullin, Richter & Hampton LLP
Mar
24
2022
New York Regulators to Jumpstart NY’s Cannabis Industry by Giving Priority to Small Businesses and Individuals with Prior Cannabis Convictions Sheppard, Mullin, Richter & Hampton LLP
Mar
23
2022
EC Requests SCCS for a Scientific Opinion on “Hydroxyapatite (Nano)” Bergeson & Campbell, P.C.
Mar
23
2022
Michigan Expands Development District Liquor License Availability Miller Canfield
Mar
23
2022
Objections Filed to Yogurt Product SOI Final Rule Keller and Heckman LLP
Mar
22
2022
Lawsuit Challenges Flavor Labeling in Product with Malic Acid Keller and Heckman LLP
Mar
22
2022
FTC and DOJ to Host Public Forums on Effects of Mergers Ahead of Issuance of New Merger Guidelines Mintz
Mar
21
2022
Ontario’s Bill 88 Would Establish Electronic Monitoring Policies, Create Rights for Workers on Digital Platforms, and Require Naloxone Kits Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Mar
21
2022
Preliminary Injunction Upheld on New Prop 65 Acrylamide Warning Label Suits Keller and Heckman LLP
Mar
19
2022
Gold Dome Report – Legislative Day 31 Nelson Mullins
Mar
18
2022
OIG Advisory Opinion Alert: Yet Another Favorable Decision for Medical Device Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Mar
18
2022
Court Determines Dreyer’s Accurately Disclosed Ice Cream Bar Ingredients Keller and Heckman LLP
Mar
17
2022
COVID-19: State Law Telehealth Considerations: State Licensure Requirements Persist, Permissible Telehealth Modalities Generally Expand, and Insurance Parity Laws Ensure Reimbursement (Part 2 of a 3-Part Series) K&L Gates
Mar
17
2022
FDA Releases Report on Guacamole Sampling Keller and Heckman LLP
Mar
17
2022
Breaking News – China Finalizes Management Rules for E-Cigarettes Keller and Heckman LLP
Mar
16
2022
FDA Receives Authorization to Regulate Synthetic Nicotine Keller and Heckman LLP
Mar
16
2022
Washington PFAS Ban For Cosmetics Stalls CMBG3 Law
Mar
16
2022
Looking into Our (Slightly Hazy) Crystal Ball: What Will the Mississippi Cannabis Market Look Like? Bradley Arant Boult Cummings LLP
Mar
16
2022
10th Circuit Confirmed Dismissal of “Product of USA” Beef Lawsuits Keller and Heckman LLP
Mar
15
2022
FDA Proposes To Harmonize Medical Device Quality System Regulations With ISO 13485 Barnes & Thornburg LLP
Mar
15
2022
The Next Wave of PFAS Regulation ArentFox Schiff LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins